• AAPL 189.82
  • TSLA 177.46
  • AMZN 184.7
  • MSFT 420.21
  • INTC 31.85
  • EURUSD 1.0872
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. BR /
  3. ARGX.BR

Argen-X (ARGX BR) stock market data APIs

€345.2 5.3(1.6%) as of May 17, 2024

Argen-X Financial Data Overview

339.9
345.2
-
348.1
339.2
271-494.1
20 201 M
59 431 K
1 451 M
-1.04
0.366
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ARGX',
Type: 'Common Stock',
Name: 'Argen-X',
Exchange: 'BR',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Belgium',
CountryISO: 'BE',
OpenFigi: NULL,
ISIN: 'NL0010832176',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '2017-05-18',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Argen-X Fundamental Data is available in our Financial Data APIs

  • Net Revenue 1 451 M
  • EBITDA -304 185 504
  • Earnings Per Share -5.23
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Argen-X Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.8

Get Argen-X End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Argen-X latest news via APIs

argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript

argenx SE (NASDAQ:ARGX) Q1 2024 Earnings Call Transcript May 9, 2024 argenx SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Ope...

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

argenx SE $398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for pre-filled syringe (PF...
Do you have any questions?
support@eodhistoricaldata.com